Tempest Therapeutics, Inc. — Director's Dealing 2013

Jun 11, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OvaScience, Inc. (OVAS)
CIK: 0001544227
Period of Report: 2013-06-07

Reporting Person: FISHER MARY (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-06-07	Stock Options (right to buy)	$14.00	A	13098	Acquired	2023-06-07	Common Stock (13098)	Direct

Footnotes

F1: The stock options will vest in twelve equal monthly installments at the end of each successive month following June 7, 2013.